A detailed history of Members Capital Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Members Capital Advisors Inc holds 1,354 shares of ABBV stock, worth $261,132. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,354
Previous 1,354 -0.0%
Holding current value
$261,132
Previous $246,000 5.69%
% of portfolio
0.27%
Previous 0.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $1.99 Million - $2.31 Million
-14,920 Reduced 91.68%
1,354 $201,000
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $264,084 - $299,775
2,482 Added 18.0%
16,274 $1.76 Million
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $1.45 Million - $1.62 Million
13,792 New
13,792 $1.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Members Capital Advisors Inc Portfolio

Follow Members Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Members Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Members Capital Advisors Inc with notifications on news.